Novel diagnostics of metabolic dysfunction detected in breath and plasma by selective isotope-assisted labeling.
Metabolomics is the study of a unique fingerprint of small molecules present in biological systems under healthy and disease conditions. One of the major challenges in metabolomics is validation of fingerprint molecules to identify specifically perturbed pathways in metabolic aberrations. This step is crucial to the understanding of budding metabolic pathologies and the ability to identify early indicators of common diseases such as obesity, type 2 diabetes mellitus, metabolic syndrome, polycystic ovary syndrome, and cancer. We present a novel approach to diagnosing aberrations in glucose utilization including metabolic pathway switching in a disease state. We used a well-defined prenatally exposed glucocorticoid mouse model that results in adult females with metabolic dysfunction. We applied the complementary technologies of nuclear magnetic resonance spectroscopy and cavity ring-down spectroscopy to analyze serial plasma samples and real-time breath measurements following selective (13)C-isotope-assisted labeling. These platforms allowed us to trace metabolic markers in whole animals and identify key metabolic pathway switching in prenatally glucocorticoid-treated animals. Total glucose flux is significantly proportionally increased through the major oxidative pathways of glycolysis and the pentose phosphate pathway in the prenatally glucocorticoid-treated animals relative to the control animals. This novel diagnostics approach is fast, noninvasive, and sensitive for determining specific pathway utilization, and provides a direct translational application in the health care field.
Department of Zoology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Julia A
JA
Haviland
Marco
M
Tonelli
Dermot T
DT
Haughey
Warren P
WP
Porter
Fariba M
FM
Assadi-Porter
D000537:Aluminum Oxide; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D001944:Breath Tests / Q000379:methods*; D002247:Carbon Isotopes; D004195:Disease Models, Animal; D004338:Drug Combinations; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006019:Glycolysis; D006854:Hydrocortisone / Q000378:metabolism; D007553:Isotope Labeling / Q000379:methods*; D019344:Lactic Acid / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D055432:Metabolomics / Q000379:methods; D051379:Mice; D010427:Pentose Phosphate Pathway; D010949:Plasma / Q000378:metabolism; D012833:Siloxanes; D013057:Spectrum Analysis / Q000379:methods*
D001786:Blood Glucose; D002247:Carbon Isotopes; D004338:Drug Combinations; D005938:Glucocorticoids; C100341:SIAL sorbent; D012833:Siloxanes; D019344:Lactic Acid; D000537:Aluminum Oxide; D006854:Hydrocortisone